Insurance

Latest News

Conference presenter | Image credit: Image credit: Right 3 - stock.adobe.com

AXS25: Health Policy, Drug Costs, and AI Highlights From the Conference

By Pearl Steinzor

May 6th 2025

Asembia’s AXS25 Summit covered a variety of relevant topics in the pharmaceutical industry, from the effects of the new administration to how artificial intelligence (AI) is reshaping the patience experience.

Telehealth appointment | Image Credit: Nattakorn - stock.adobe.com

Telepsychiatry Services Cut Hospitalization Rates Without Raising Overall Costs

By Brooke McCormick

May 5th 2025

Semaglutide injectors. | Image Credit :Andreas Prott- stock.adobe.com .jpeg

Novo Nordisk Expands GLP-1 Access Through Telehealth Providers

By Pearl Steinzor

May 1st 2025

Health insurance application | Image credit: Annap - stock.adobe.com

Aetna Members With ACA Plans Will Need New Coverage in 2026; CVS to Exit ACA Marketplace

By Julia Bonavitacola

May 1st 2025

Prescription drug costs | Image credit: Mark Aplet - stock.adobe.com

Drug Affordability Challenges in the “Patient as Payer” Era

By Pearl Steinzor

May 1st 2025

More News

Anti-Angiogenesis in NSCLC

Anti-Angiogenesis in NSCLC

Watch

Nondriver NSCLC: Immunotherapy and PD-L1 Expression

Nondriver NSCLC: Immunotherapy and PD-L1 Expression

Watch

Immunotherapy and Chemotherapy in Second-Line NSCLC

Immunotherapy and Chemotherapy in Second-Line NSCLC

Watch

NSCLC: Initiating Second-Line Therapy

NSCLC: Initiating Second-Line Therapy

Watch

Maintenance Following Chemotherapy in NSCLC

Maintenance Following Chemotherapy in NSCLC

Watch

Nondriver NSCLC: Frontline Systemic Therapy

Nondriver NSCLC: Frontline Systemic Therapy

Watch

Mutation Testing in Nonsquamous NSCLC

Mutation Testing in Nonsquamous NSCLC

Watch

Incentivizing Quality Care in NSCLC

Incentivizing Quality Care in NSCLC

Watch

Considering Real-World Outcomes in NSCLC

Considering Real-World Outcomes in NSCLC

Watch

Second-Line NSCLC Coverage Decisions

Second-Line NSCLC Coverage Decisions

Watch

Molecular Testing Coverage Decisions in Lung Cancer

Molecular Testing Coverage Decisions in Lung Cancer

Watch

Communicating Policy Changes in Lung Cancer

Communicating Policy Changes in Lung Cancer

Watch

Clinical Pathways in NSCLC

Clinical Pathways in NSCLC

Watch

Lung Cancer: Novel Combinations

Lung Cancer: Novel Combinations

Watch

The REVEL Study in Lung Cancer

The REVEL Study in Lung Cancer

Watch

Alternative Payment Models and Quality in Lung Cancer

Alternative Payment Models and Quality in Lung Cancer

Watch

Rationale for Anti-Angiogenesis in Lung Cancer

Rationale for Anti-Angiogenesis in Lung Cancer

Watch

Role of Immunotherapy in Lung Cancer

Role of Immunotherapy in Lung Cancer

Watch

Deciding on Second-Line Lung Cancer Therapy

Deciding on Second-Line Lung Cancer Therapy

Watch

Frontline Decision Making in Nondriver Lung Cancer

Frontline Decision Making in Nondriver Lung Cancer

Watch

Outcomes-Based Contracting in Lung Cancer

Outcomes-Based Contracting in Lung Cancer

Watch

Cost-Benefit Analysis in Lung Cancer

Cost-Benefit Analysis in Lung Cancer

Watch

Current Biomarkers in Lung Cancer

Current Biomarkers in Lung Cancer

Watch

Assessing Options in Second-Line NSCLC

Assessing Options in Second-Line NSCLC

Watch

Molecular Testing in NSCLC and Cost

Molecular Testing in NSCLC and Cost

Watch

Integrating New Lung Cancer Drugs Into a Formulary

Integrating New Lung Cancer Drugs Into a Formulary

Watch

Clinical Pathways in Lung Cancer

Clinical Pathways in Lung Cancer

Watch

5 Elements of a Strategy to Fight Loneliness in Seniors

The integrated health plan has a strategy to combat the effects of isolation and its effects, which increase the risk of Alzheimer's disease, obesity, and hospital readmissions.

Read More

The Future of Healthcare in the United States

The Future of Healthcare in the United States

Watch

How Will an ACA Repeal Affect Healthcare?

How Will an ACA Repeal Affect Healthcare?

Watch

...

35 36 37 38 39 40 41 42 43

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions